Diabetes NDCs WAC Increases

This dataset is a subset of the CTRx data presenting diabetes related treatments. This table is a list of wholesale acquisition cost (WAC) increases that exceed the WAC increase threshold of 16% for the period including the current quarter and the previous two calendar years for prescription drug products with a WAC greater than $40 for a course of therapy. HCAI also reports on preventable hospitalizations for diabetes: https://hcai.ca.gov/visualizations/preventable-hospitalizations-for-diabetes/. The diabetes drugs included in this analysis are based on the Nevada Department of Health and Human Services’ Essential Diabetes and Asthma Drug List: https://dhhs.nv.gov/HCPWD/Drug_Transparency